The Sarver Heart Center at University of Arizona -Tucson, is presenting four Green Valley lectures from January to April in 2020.
As an undergraduate, Chinyere began performing research in the UA Sarver Heart Center under the mentorship of accomplished physician-scientists, including Steven Goldman, MD, professor of medicine, Elizabeth Juneman, MD, associate professor of medicine, and Jil Tardiff, MD, PhD, professor of medicine and cellular and molecular medicine. Chinyere, now an MD/PhD candidate in the UArizona College of Medicine - Tucson, has been developing a platform to evaluate drug effectiveness and toxicity for different conditions, such as heart failure and atrial fibrillation.
“African-American race negatively influenced the decision-making process for heart transplants, especially during discussions among health care providers,” said lead author Khadijah Breathett, MD, MS, an assistant professor of medicine and advanced heart failure/transplant cardiologist at the University of Arizona’s Sarver Heart Center. “Since advanced therapy selection meetings are conversations rather than surveys, race may contribute significantly to treatment recommendations.”
The University of Arizona Division of Pediatric Cardiology Congenital Heart Program will explore the public health problem of congenital heart defects among children, adolescents and adults.
Here is a recap of some of the lectures, presentations, publications and research award of University of Arizona Sarver Heart Center members
The Inter-societal Accreditation Commission (IAC) fully re-accredited the Banner - University Medical Center Echocardiography Laboratory for five types of heart ultrasound, or echocardiograms.
The number of adults diagnosed with diabetes has more than doubled during the past 20 years as the American population has aged and become more overweight. This number may be reduced if more people are screened for prediabetes, a condition that affects 84 million in which 90% don't know they have it.
Personalized medicine in a dish. A collaborative research team is searching for genetic themes among family members who share a high prevalence of bicuspid aortic valve disease. They are testing medical therapies on cellular models grown in the lab from stem cells derived from each family member. Their goal is to more precisely predict which therapies would manage the conditions effectively.
When Chip Rock learned he needed a heart valve replacement, he considered his mother’s experience. She, at age 92, was one of the first TAVR patients in February 2014, when the UA Sarver Heart Center Structural Heart Team offered the procedure only for high-risk patients. “My mother did well for several years after her procedure, so when I learned I needed a valve replacement, I contacted Dr. Lotun to see what he could do for me,” Rock said.
The Diabetes/Heart Disease Connection Lunch and Learn Program is a community education program presented in collaboration with the University of Arizona Sarver Heart Center’s Women’s Heart Health Education Committee.